BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33494881)

  • 1. Hemolytic Disease of the Fetus and Newborn: Historical and Current State.
    Jackson ME; Baker JM
    Clin Lab Med; 2021 Mar; 41(1):133-151. PubMed ID: 33494881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
    De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
    Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C causing severe hemolytic disease of the fetus and newborn: a rare case report.
    Sahoo D; Anuragaa S; Abhishekh B
    Immunohematology; 2023 Apr; 39(1):11-14. PubMed ID: 37017597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
    Delaney M; Matthews DC
    Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D; Lopriore E
    BMC Pregnancy Childbirth; 2023 Oct; 23(1):738. PubMed ID: 37853331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of Hemolytic Disease of the Fetus and Newborn Treated Without Blood Products.
    Hirschman L; Munchel A
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):e118-e120. PubMed ID: 38032187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
    Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
    Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jk3 alloantibodies during pregnancy-blood bank management and hemolytic disease of the fetus and newborn risk.
    Lawicki S; Coberly EA; Lee LA; Johnson M; Eichbaum Q
    Transfusion; 2018 May; 58(5):1157-1162. PubMed ID: 29479723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and management of fetal anemia due to hemolytic disease.
    van 't Oever RM; Zwiers C; de Winter D; de Haas M; Oepkes D; Lopriore E; Verweij EJJ
    Expert Rev Hematol; 2022 Nov; 15(11):987-998. PubMed ID: 36264850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates.
    Tyndall C; Cuzzilla R; Kane SC
    Transfus Apher Sci; 2020 Oct; 59(5):102948. PubMed ID: 33008742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn.
    McCarthy WA; Popek EJ
    Pediatr Dev Pathol; 2017; 20(6):469-474. PubMed ID: 29187036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
    Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
    AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical model for prediction of ABO hemolytic disease of the fetus and newborn in India.
    Patale DS; Lokhande TL; Chaudhary RK
    Immunohematology; 2021 Jun; 37(2):64-68. PubMed ID: 34170645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Andersen LH; Jacob EK; McThenia SS; Tauscher CD; Patterson ER; Oliveira JL; Rodriguez V
    Transfusion; 2021 Mar; 61(3):974-978. PubMed ID: 33444461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
    He Y; Gao W; Li Y; Xu C; Wang Q
    Transfusion; 2023 Mar; 63(3):494-506. PubMed ID: 36727659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.